Pharmacytimes: Condition Center: Pain Management http://www.pharmacytimes.com/condition-resources/pain/condition-rss Pain Management en-us Thu, 23 Mar 2017 04:11:01 UTC Thu, 23 Mar 2017 04:11:01 UTC Intensive Outpatient Pain Management Cost-Effective for Treating Patients with Chronic Pain http://www.pharmacytimes.com/resource-centers/pain/intensive-outpatient-pain-management-shown-as-costeffective-for-treating-patients-with-chronic-pain- An interdisciplinary treatment modality is especially effective when treating patients with chronic pain. 2:03 PM, Mon March 20, 2017 Pain Management in End Stage Renal Disease http://www.pharmacytimes.com/contributor/jeffrey-fudin/2017/02/pain-management-in-end-stage-renal-disease Prescribers and pharmacists in various clinical roles are often challenged when treating patients with comorbid chronic pain and end-stage renal disease (ESRD) or hemodialysis (HD). There is a dearth of clinical guidelines available for chronic pain management in this setting. Those selecting pharmacotherapy for patients must rely on clinical judgement, literature analysis and prudent decision making. 11:51 PM, Sun February 26, 2017 New Jersey Enacts Strict Opioid Prescribing Law http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/02/new-jersey-enacts-strict-opioid-prescribing-law On February 15 2017, Governor Chris Christie of New Jersey signed legislation aimed to curb the state’s opioid addiction epidemic 8:43 PM, Mon February 20, 2017 Patient Opioid Abuse Could Depend on ER Physician http://www.pharmacytimes.com/resource-centers/pain/patient-opioid-abuse-could-depend-on-er-physician A new study published today in <em>The New England Journal of Medicine </em>casts new light on the severity of the opioid abuse crisis in the United States. Nearly one out of 48 people who are newly prescribed an opioid will become long-term users, the study&rsquo;s lead author said. &nbsp;<br /> &nbsp; 3:09 PM, Thu February 16, 2017 Study: Yoga Provides Relief for Low Back Pain http://www.pharmacytimes.com/resource-centers/pain/study-yoga-provides-relief-for-low-back-pain <p>Yoga performed about the same as non-yoga exercise in terms of improving back function at 3 and 6 months, although the researchers found few studies comparing yoga to other exercise and therefore considered the evidence to be very low certainty.</p> 12:26 PM, Mon February 13, 2017 Patient Counseling: Most Important Opioid Warnings http://www.pharmacytimes.com/contributor/steve-leuck-pharmd/2017/01/patient-counseling-most-important-opioid-warnings Before you read this article, take a moment and see if you remember the 7 or 8 black box warnings associated with long acting opioid pain medications. 4:33 AM, Mon January 30, 2017 Elite Files Application for Generic Hydrocodone, Acetaminophen Combination http://www.pharmacytimes.com/product-news/elite-files-application-for-generic-hydrocodone-acetaminophen-combination- Officials with Elite Pharmaceuticals have filed an abbreviated new drug application with the FDA for a generic version of Norco (hydrocodone bitartrate and acetaminophen tablets) in doses of 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg. 1:00 AM, Wed December 21, 2016 AcelRX Submits NDA to FDA for Investigational Pain Product http://www.pharmacytimes.com/product-news/acelrx-submits-nda-to-fda-for-investigational-pain-product- AcelRX has submitted&nbsp;a New Drug Application (NDA) to the FDA for ARX-04 (sufentanil tablets). 9:40 AM, Tue December 13, 2016 Pharmacists Have Role to Play in Minimizing Fall Risk http://www.pharmacytimes.com/news/pharmacists-have-role-to-play-in-minimizing-fall-risk Falls can cause significant mortality and morbidity in the aging population. 8:31 AM, Tue December 13, 2016 Egalet Submits sNDA to the FDA for Abuse-Deterrent Oxaydo http://www.pharmacytimes.com/product-news/egalet-submits-snda-to-the-fda-for-abusedeterrent-oxaydo Egalet has submitted&nbsp;a supplemental new drug application (sNDA) to the FDA for Oxaydo, (oxycodone HCl, USP) in favor of an abuse-deterrent label claim for the intravenous route of abuse. 9:49 AM, Thu December 1, 2016 Melatonin Is Good for Migraine Headaches, Study Results Show http://www.pharmacytimes.com/contributor/charles-ng-pharmd-mba-candidate-2017/2016/09/melatonin-is-good-for-migraine-headaches-study-results-show Melatonin: it’s more than just a sleep aid. 4:00 AM, Thu September 29, 2016 Meperidine: Friend or Foe? http://www.pharmacytimes.com/contributor/orlando-alvarado-rivera-pharmd-ms/2016/09/meperidine-friend-or-foe Meperidine was synthetically derived in 1939 as an anticholinergic agent, but was discovered to possess analgesic properties shortly after. 5:06 AM, Tue September 27, 2016 A Potential Solution to Opioids' Adverse Effects http://www.pharmacytimes.com/contributor/patrick-wieruszewski-bs-pharmd-candidate-2016/2016/08/a-potential-solution-to-opioids-adverse-effects As computational techniques become more sophisticated, the idea of targeted therapeutic treatments sans adverse effects could become reality. 12:51 AM, Mon August 22, 2016 IV, PO, and PR Acetaminophen: A Quick Comparison http://www.pharmacytimes.com/contributor/stephanie-nam-pharmd-candidate-2017/2016/08/iv-po-and-pr-acetaminophen-a-quick-comparison Although their pharmacokinetics are all similar, here’s how they differ. 11:40 PM, Thu August 18, 2016 Pain Assessment Scales: An Overview for Pharmacists http://www.pharmacytimes.com/contributor/jola-mehmeti-pharmd-mba-candidate-2018/2016/07/pain-assessment-scales-an-overview-for-pharmacists Patients benefit when pharmacists thoroughly assess pain. 10:55 PM, Thu July 14, 2016 Reassessing Routine Refills for Cyclobenzaprine http://www.pharmacytimes.com/contributor/jeffrey-fudin/2016/06/reassessing-routine-refills-for-cyclobenzaprine Pharmacists in all health care settings commonly see what seems like lifelong refills for cyclobenzaprine for musculoskeletal conditions. 2:50 AM, Tue June 28, 2016 Abuse-Deterrent Pain Treatment Rejected by FDA http://www.pharmacytimes.com/product-news/abuse-deterrent-pain-treatment-rejected-by-fda The FDA has rejected KemPharm Inc’s benzhydrocodone and acetaminophen (Adapaz), a potential abuse-deterrent treatment for acute pain. 7:00 AM, Mon June 27, 2016 Chest Pain Treatment GoNitro Approved http://www.pharmacytimes.com/product-news/chest-pain-treatment-gonitro-approved The FDA has approved Espero Pharmaceuticals Inc’s nitroglycerin sublingual powder (GoNitro) for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. 7:00 AM, Wed June 22, 2016 Pain Management Is Changing, But Is It for the Better? http://www.pharmacytimes.com/contributor/fred-eckel-rph-ms/2016/06/pain-management-is-changing-but-is-it-for-the-better A recent experience made me realize that pain management is changing. 11:16 PM, Tue June 21, 2016 3 Facts About Dormant Butt Syndrome http://www.pharmacytimes.com/news/3-facts-about-dormant-butt-syndrome It may have a funny name, but dormant butt syndrome causes some patients to experience knee, back, or hip pain. 10:00 PM, Thu June 16, 2016